Oral Anticoagulation Therapy Cases and Clinical Correlation /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Kiser, Kathryn (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
• Θέματα: Medicine.; Cardiology.; Medicine & Public Health.

This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider...

Πίνακας περιεχομένων:

• Atrial Fibrillation: Basic simple introductory case
• Patient who desires best reduction in ischemic stroke possible
• Elderly patient (e.g. > 80 years old)
• Patient with prior history of GI hemorrhage
• Patient with history of intracranial hemorrhage while on warfarin
• Patient with history of adherence issues who uses pill box
• Patient with stable moderate chronic kidney disease
• Patient with variable renal function
• Patient with concomitant coronary artery disease
• Patient with concomitant history of venous thromboembolism
• Venous Thromboembolism (VTE): Patient with new DVT
• Patient with new PE
• Patient s/p hip replacement
• Patient in ICU in need of DVT prophylaxis
• Patient with VTE and concomitant atherosclerotic disease
• Patient with DVT in ICU with feeding tube
• Patient with moderate chronic kidney disease and VTE
• Patient with recurrent VTE
• Patient with PE who underwent thrombolytic therapy
• Patient s/p knee replacement
• Acute Coronary Syndrome: Patient on a new oral anticoagulant presenting with ACS
• Patient post PCI
• Patient with ACS with additional indication for oral anticoagulant
• Patient with ST segment elevation MI (lytic candidate) on new oral anticoagulant
• Patient with ACS who will be undergoing bypass surgery
• Drug Interactions: CYP 3A4 inhibitors
• PgP inhibitors
• Pharmacodynamic interactions
• Mixed CYP 3A4/PgP inhibitors
• Plausible (but unproven) drug interactions (e.g. cyclosporine)
• Special Populations: Atrial fibrillation ablation
• Mechanical valves
• Coagulopathies
• Pregnancy
• Malignancies
• Perioperative management-minor procedures
• Perioperative management-major procedures.